Stakeholder Insight: Osteoporosis - Generic alendronate further establishes oral bisphosphonates as gold standard

Published Date: October 2008 Published By: Datamonitor Page Count: 199 Order Code: R313-41440 $15,200.00   Online Download $30,400.00   Global Site License   Questions About This Report E-mail a Colleague Printable Page Fax Your Order Description Table of Contents Similar Products The most important factors that physicians consider when prescribing drugs for osteoporosis are efficacy on bone mineral density and fracture risk reduction. Bisphosphonates reached similar scores on efficacy and safety in Datamonitor's physician survey, but are differentiated in terms of cost, flexibility of administration, and intermittent dosing Reasons to Purchase Target physicians more effectively through an understanding of prescribing behavior and its influences. Validate new product forecasting based on diagnosis and treatment rates, and the likely rate of uptake for new products Benchmark brand awareness and perceptions surrounding product positioning in order to formulate competitive lifecycle management strategies. Please Note: This product is delivered as a zip file Similar Products • Pharmaceutical Alliance Management Published Jan 2009 by Cutting Edge Information • New Drug Development from Existing Drugs Published Dec 2008 by Trimark Publications • What Is the Future Role of Predictive Safety Biomarkers in Drug Development? Published Dec 2008 by Decision Resources • URINARY TRACT INFECTIONS Therpay Pipeline Report Published Dec 2008 by Life Science Analytics (LSA) • MALARIA Therpay Pipeline Report Published Dec 2008 by Life Science Analytics (LSA) • HELMINTHIC INFESTATIONS Therpay Pipeline Report Published Dec 2008 by Life Science Analytics (LSA) • FUNGAL INFECTIONS OR CANDIDIASIS Therpay Pipeline Report Published Dec 2008 by Life Science Analytics (LSA) • FEVER Therpay Pipeline Report Published Dec 2008 by Life Science Analytics (LSA) • EAR INFECTIONS Therpay Pipeline Report Published Dec 2008 by Life Science Analytics (LSA) • BACTERIAL INFECTIONS Therpay Pipeline Report Published Dec 2008 by Life Science Analytics (LSA)